Rosalie Dunn, Ph.D., has joined Gwathmey, a preclinical CRO, as chief executive officer. Dr. Dunn has more than 28 years of experience working with small businesses and the federal government. Prior to joining Gwathmey, Dr. Dunn managed multimillion dollar portfolios for the National Institutes of Health (NIH), including cardiovascular devices and technologies, clinical studies, imaging applications, development of new animal models, bioengineering projects, sleep research, computer models, athe...